About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Scientists Discover Achilles' Heel of Influenza

by Sheela Philomena on April 11, 2014 at 12:20 PM
Font : A-A+

 Scientists Discover Achilles' Heel of Influenza

Influenza H1N1 flu virus has been a deadly virus and not much is available for its treatment, but now the scientists may have discovered its Achilles heel and may have a drug that can treat the lethal dose of the virus.

The study reveals that a drug that inhibits a molecule called prostaglandin E2 (PGE2) increases survival rates in mice infected with a lethal dose of the H1N1 flu virus.

Advertisement

Senior study author Maziar Divangahi of McGill University, said drugs that specifically target PGE2 pathways have already been developed and tested in animals, so their results have excellent potential for clinical translation, not only for the treatment of influenza, but also other viral respiratory infections that interact with similar host immune pathways.

In the new study, Divangahi and his team found that mice genetically engineered to lack PGE2 showed enhanced immune responses, lower viral levels in the lungs, and better survival rates following infection with a lethal dose of the H1N1 flu virus compared with infected mice that were not genetically modified.

Similarly, mice treated with a compound that inhibits PGE2 showed enhanced antiviral immunity and survival rates following infection with a lethal dose of the flu virus compared with untreated mice.

The study has been published by journal Cell Press.

Source: ANI
Advertisement
Advertisement

Recommended Reading

open close
CONSULT ONLINE WITH A DOCTOR

×

Scientists Discover Achilles' Heel of Influenza Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests